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Introduction
The extent of agglutination of latex..particles may be
measured with accuracy and precision by counting the
residual non-agglutinated particles with a blood cell counter
[1]. When the particles are coated with antibodies (Ab),
antigens (Ag) can be used as agglutinators. The extent of
agglutination will then depend on the concentration of Ag.
This principle is called particle counting immunoassay
(PACIA) and has been shown to be suitable for the deter-
mination of proteins [1 ]. However studies of accuracy and
precision, as well as comparison with other techniques have
not been made. In the present work, it is shown that a
clinically useful assay for human placental lactogen (hPL)
using PACIA is feasible and offers an alternative to radio- and
enzymo-immunoassays.
Materials and .methods
Antigen and antiserum
Purified hPL for standard solutions and immunisation was
supplied by ILS Ltd, (48-50 Bartholomew Close, London
EC1 U.K.). Standard solutions were prepared by serial
dilution of a concentrated solution of hPL in normal male
serum or in 0.1 M glycine-Na0H buffer pH 9, containing
9 g/1 NaC1 (GBS) and g/1 bovine serum albumin (BSA).
Antiserum was raised in a goat. The immunogen was dis-
solved in 0.9% NaC1, and ml (100/ag hPL) emulsified with
ml of complete Freund’s adjuvant was injected intra-
dermally in several sites. The animal was immunised on days
0, 14, 28, 56, 70, 98 and 112, and bled on day 126 for the
antiserum used in the tests reported here. IgG was purified
from the antiserum by precipitation of other serum proteins
with 6, 9-diamino-2-ethoxyacridine lactate (Rivanol). Four
volumes of a 0.4% (w/v solution of Rivanol in water were
added to volume of antiserum and. the glutinous preci-
pitate centrifuged at 5,000 g for 5 min. Excess Rivanol in
the supernatant was precipitated by the addition of 125
saturated NaBr per ml of antiserum treated, followed by
centrifugation (at 10,000 g for 10 rain). The supernatant was
dialysed overnight at 4 C against 0.9% NaC1 to remove traces
of Rivanol. This IgG solution was used for coating latex and
for the preparation of F(ab’)2 fragments by pepsin digestion
as described elsewhere [2].
Particles
A 50/al aliquot of particle suspension (1.1 bt diameter, 10 %
w/w, Dow Chemical Co., Indianapolis, USA) was incubated
at room temperature with mg IgG or 100/.tg F(ab’)2 in
ml of 5-fold .diluted GBS (dGBS). For IgG, incubation was
for 30 min; then mg of BSA in a small volume of dGBS was
added for a further 15 min incubation. For F(ab’)2 incubation
was for 45 min in the presence of mg BSA. After incubation
the latex was washed twice with ml GBS, by centrifugation
at 10,000 g for 5 min. After the final wash the latex was
resuspended in 2 ml GBS with mg BSA/ml, left for 24 h at
4 C, centrifuged and resuspended in ml GBS with mg
BSA/ml. It was then ready for use.
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Figure 1. Flow diagram of manifold (ml/min). All fittings
were standard Technicon parts, as follows:-
a PT2; c 157-0303-02; d 2 x 190-0051-03; f 116-
0127-02; g A9; h A14; D1; ] 190-0051-06; k
Ab; A9; m A12; n D1; o 190-0051-17; p all
except ]’or the following: b PT13 fitting modified so
that the exit tube along the long axis had an internal
diameter of 1.0 mm; e resample fitting, modified with an
extra side-inlet tube for immediate re-bubbling of the
reagent stream. Additive was generally GBS containing 10
gBSA/1.
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Instruments
Particles were counted in the Technicon AutoCounter
(Tarrytown, New York, USA) modified electronically so
that an upper as well as a lower threshold could be set on
the signal from the photomultiplier tube. With the upper
threshold, single (unagglutinated, monomer) could be dis-
criminated from multiple (agglutinated, polymer) particles.
While this modification is useful in that it increased sensi-
tivity by about 10 %, it is not essential to the basic technique.
The electronic device can be obtained from Technicon
Instruments, Dublin, Eire.
Tests were at first carried out manually. Aliquots of Ab-
coated latex and sample were agitated in 5 ml polystyrene
test-tubes on the turntable of a vortex mixer for 20 min,
then diluted with 5 ml GBS. Using a Technicon Sampler IV,
pump and manifold, aliquots were taken from these tubes,
diluted 10- to 40- fold, and passed through the flow cell of
the AutoCounter. The final dilution step was calculated to
give a maximum of about 3000 particles/sec passing through
the flow-cell. The AutoCounter output was continuously
traced on a variable-gain 2-pen strip-chart recorder, to record
the concentrations of monomer and polymer particles.
Having established that the particle-counting system gave
a good reliable response to antigen (hPL)in the samples, the
technique was automated using the Technicon continuous-
flow system (Figure 1). The manifold was slightly different
from that described previously [1]. Samples of serum,
suitably prediluted in GBS were aspirated from a Sampler IV
at 30 samples/hour with 1:1 sample/wash ratio. The sampler
had an extra arm carrying two probes to aspirate Ab-coated
latex and another solution (additive) at the same time as the
sample. The additive was generally GBS containing 10 g
BSA/1 to which different reagents, e.g. PEG (polyethylene
glycol, mol wt 6000D) or free anti-hPL, were added for
specific experiments. The pumping rates were 50/,tl/min for
sample and latex, and 100 /al/min for the additive. Before
the three reagents were mixed in a PT13 fitting, the additive
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stream was segmented with 100/J1/min of air. The reagent
mixture was then pumped through plastic tubing to two
incubation coils mounted vertically and in series on a simple
vibrator. The vibrating motion was imparted by an induction
motor oscillating a spring loaded platform upon which the
coils had been mounted. The coils executed a side-to-side
motion of mm amplitude at a frequency of 50 Hz.
A simply-segmented reagent stream tended to break up
during passage through the vibrated coil. By segmenting the
"additive" stream before mixing, a number of small air
bubbles was introduced between each segmenting bubble,
and these stabilised the reagent stream during incubation.
The reagent stream, on leaving the incubation coils, was
passed through a special resampling fitting, with practically
no dead volume. The aliquot removed was immediately re-
segmented with air and then twice diluted in series, with GBS
containing 0.025 % v/v Tween 20 before being pumped
through the AutoCounter flow-cell. The incubation time of
the reaction mixture was 24 min, and the total throughput
time, 31 min.
Results
Manual version
The effect of incubation time was tested using the manual
version of PACIA. Increased time markedly enhanced the
agglutination and improved the sensitivity (Figure 2). With a
20 min incubation, 0.1/ag[1 of hPL could easily be detected.
But, as a result of hand pipetting and dilution steps, the co-
efficient of variation within assay reached 10 %. Accordingly,
the automated system was used to obtain all the other results
reported.
Effect of concentration of particles and
their antibody loading
Increasing the concentration of particles increased markedly
their agglutinability (Figure 3). The same effect was observed
as a result of changing the concentration of IgG with which
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Figure 2. Effect of incubation time on the agglutination
of anti-hPL latex by hPL. 10 Il aliquots of latex reagent
and GBS containing 1 g/1 BSA and the indicated con-
centration of hPL were incubated for various times and
processed by the manuql technique described in Materials
and methods. Peak height represents the concentration of
particles in arbitrary units.
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Figure 3. Effect of latex concentration on its agglutination
by hPL. The determination was carried out with the
automated system, aspirating samples of GBS containing
1 mg BSA/ml and the indicated concentration of hPL,
latex at a concentration of 0.5 %, 0.25 %, 0.125 %
or 0.0625 % (w/v), and an additive of GBS with 10 g
BSA/1. Particle concentration is expressed as chart peak
height, adjusted for maximal response for each concen-
tration of latex.
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the particles were prepared, i.e. the amount absorbed onto
their surfaces (Figure 4). The relationship between IgG con-
centration and surface absorption has been described
elsewhere [3 ].
Sensitivity
Polymers such as dextran or PEG enhance, immunological
agglutination or precipitation [4]. The sensitivity of the
assay of hPL by PACIA in the presence of PEG was clearly
increased (Figure 5). Without PEG, 5 #g/1 of hPL could
barely be detected, whereas in the presence of 20 g/1 of
PEG, 5 #g/1 of hPL decreased the number of particles by
75 %. According to Hellsing [4], this effect of PEG coul,d
be explained in terms of a steric exclusion of the AgAb
complexes from the domain of the polymer. It must be
noted that PEG is not effective in all applications of PACIA
(in preparation).
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Figure 4. Effect of different anti-hPL IgG loadings of
latex on its agglutination by hPL. Conditions as for Figure
3, but using different latex preparations prepared as
described in Materials and methods, incubation being at
the various lgG concentrations indicated.
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Figure 5. Effect of PEG6000 on the agglutination of anti-
hPL latex reagent by hPL measured with the automated
system. Serum samples with indicated hPL concentrations
diluted 1:200 with GBS, were aspirated with latex and
an additive of GBS containing 1 g BSA/1 and PEG for
final concentration as indicated.
The sensitivity of the system could also be increased by
using the ratio of the concentrations of unagglutinated
(monomer) to agglutinated (polymer) particles, instead of
that of monomers alone (Figure 6). The initial slope of the
standard curve obtained with this ratio was also steeper. In
the presence of low concentrations of agglutinator there is
a small reduction in the large number of monomers, but a
proportionately larger increase in the small number of
polymers. Hence, the use of the ratio will give a greater
response to a given concentration of Ag than will the use
of the monomer concentration, and will also give a more
accurate response than that of polymer concentration where
only a few particles are counted.
Table 1. Reduction of the latex count by various rheumatoid
sera as the percentage of the number of particles
before addition of the agglutinator
Serum from patients named
Gui Juv Ler Mac
IgG-coated latex 68 53 82 32
F(ab’)-coated latex 2 1.5 0.5 2.5
Table 2 Inter-assay precision of hPL standard curve
measurement
hPL concentration
(mg/1)
2
4
6
8
10
16
Peak height or particle concentration
in arbitrary units
Mean Standard
deviation
1.5
1.55
2.15
2.4
2.0
1.35
0.6
92.1
8O.5
59.0
42.5
32.4
27.4
21.2
Coefficient
of variation
1.63%
1.93 %
3.64 %
5.65 %
6.17%
4.93%
2.83 %
Assays were run on the PACIA automated system on 5 successive
days.
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Figure 6. Standard curves from automated PACIA assay.
Serum samples containing indicated concentrations of
hPL diluted 1:400 with GBS were aspirated with latex,
and GBS (50 g BSA/1). Results expressed in concen-
tration of monomer particles, or the ratio ofmonomer to
polymer particle concentrations.
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Accuracy and precision
When the agglutination reaction was carried out in serum
several effects were observed. Normal sera, in general, caused
a decrease in specific agglutination and in the sensitivity of
the reaction (Figure 7). There was also a nonspecific agglut-
ination of the Ab-coated latex (Figure 7). These effects were
much less marked with latex coated with the F(ab’)2
fragments of the goat igG anti-hPL. This F(ab’)2-1atex also
prevented the agglutination by rheumatoid factor. Four
rheumatoid sera diluted 1/200 in GBS strongly agglutinated
IgG-latex, but not the F(ab’)2-1atex (Table 1).
Thirty-two serum samples from an obstetric clinic were
assayed by PACIA, and the results compared with those
obtained with "Phadebas" RIA. Initially, either IgG-latex
with sera diluted 1/1000, or F(ab’)z-latex with sera diluted
1/250 were used. However, by adding free anti-hPL to the
reagent stream it was possible to decrease the sensitivity of
the reaction sufficiently to use a more practical dilution of
1/10 with no loss of precision or accuracy. The correlation
between the results by PACIA and by radioimmunoassay
using the 1/250 dilution is shown in Figure 8; similar results
were obtained using the other dilutions, i.e. 1000 and 10.
The precision of the fully automated PACIA was tested
by running hPL standard curves with two batches of IgG-
latex each day for a week (Table 2). The inter-assay
coefficient of variation for each standard concentration was
less than 6.5 %.
Discussion
The present results confirmed the potential of PACIA for the
determination of proteins. The sensitivity ofPACIA as applied
to hPL is impressive. With a 20 min incubation this method
can measure concentrations that require an incubation of 20
hours in radioimmunoassay. In the best conditions ofPACIA,
0.1 /.tg/1 of hPL (4.5 x 10-M) reduced the number of
particles by 10 %. The latex concentration being 0.86 x
10 particles/I, 54 molecules were necessary to agglutinate
2 particles.
Serum interference was discussed in detail previously [2].
Non-specific agglutination is mainly due to rheumatoid
factor, which is found in many sera when a sensitive aggluti-
nation technique is used. The use of F(ab’) fragment
prevents this type of interference and, to some extent, the
agglutination inhibition produced by some sera. It is sus-
pected that the inhibitory factor is IgG rheumatoid factor
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which, by coating the particles, masks the antibodies and
hence decreases the agglutinability of the particles.
As a practical assay system PACIA has both unrealised
potential and advantages over other techniques. It has
adequate sensitivity for the determination of most proteins
of biological and clinical interest and seems to be more
rapid than most other techniques. PACIA also has the
advantages of not using radioisotopes and of allowing easy
automation. Applications of PACIA to the determination
of rat IgA idiotypes [5], mouse anti-IgG autoantibodies [6],
and circulating immune complexes 3,7,8] have been
reported. The agglutination has been measured with a Coulter
counter model ZB 8 ].
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Figure 7. Effect of human serum on the agglutination of
anti-hPL latex by hPL, measured with the automated
system Samples of hPL in GBS (1 g BSA/1) were
aspirated with latex, and various dilutions of normal
human serum or GBS containing 50 g/1 BSA.
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Figure 8. Correlation of results for the determination of
hPL in sera of pregnant women measured by RIA and
PACIA with the automated system. Serum diluted 1:250
with GBS was aspirated with anti-hPL F(ab’) latex. The
regression was calculated using the power model log
y b log x + log a.
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